April 20, 2016 — Mirada Medical announced a new agreement to work with the clinicians and physicists at The Christie Hospital in Manchester, England, a world-renowned centre for complete cancer care. The Christie is the only U.K. hospital that will be treating cancer patients with proton therapy and magnetic resonance imaging (MRI)-guided linear accelerators (LINAC), whilst benefiting from the latest advancements in diagnostics with positron emission tomography (PET)/MRI.
With Mirada specializing in software to enable collaboration between departments and treatment methods, this is a natural relationship that will support fundamental changes in treatment protocols, reducing time to treatment whilst improving clinical confidence and efficacy.
“We have chosen Mirada as strategic partner to develop multimodality imaging solutions because of the quality of their software, allowing rapid translation of novel techniques into our clinic while also providing the possibility to efficiently integrate workflows for the different treatment techniques that are available at our site,” said Prof. Marcel Van Herk, chair in radiotherapy physics at the University of Manchester and The Christie NHS Foundation Trust.
For more information: www.mirada-medical.com
October 16, 2026 
